Search Results | Diabetes | American Diabetes Association

1-20 of 30

Sort by

Sort Order Select

Meeting Abstracts

33-OR: ADA Presidents' Select Abstract: Glycemic Outcomes over 12 Months in Very Young Children with the Omnipod 5 Automated Insulin Delivery (AID) System

DANIEL DESALVO, BRUCE W. BODE, GREGORY P. FORLENZA, LORI M. LAFFEL, BRUCE A. BUCKINGHAM, AMY B. CRIEGO, MELISSA SCHOELWER, SARAH A. MACLEISH, JENNIFER SHERR, DAVID W. HANSEN, TRANG T. LY, GROUP OMNIPOD 5 IN PRESCHOOLERS STUDY

Diabetes 2022;71(Supplement_1):33-OR

DOI: https://doi.org/10.2337/db22-33-OR

Published: 01 June 2022

View article

Meeting Abstracts

766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years

Diabetes 2022;71(Supplement_1):766-P

DOI: https://doi.org/10.2337/db22-766-P

Published: 01 June 2022

View article

Meeting Abstracts

765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years

Diabetes 2022;71(Supplement_1):765-P

DOI: https://doi.org/10.2337/db22-765-P

Published: 01 June 2022

View article

Meeting Abstracts

92-OR: Persistence of Impaired Awareness of Hypoglycemia, Severe Hypoglycemic Events, and Suboptimal Glycemic Control Despite Advanced Diabetes Technologies

JEREMY PETTUS, JINGWEN LIU, LINA TITIEVSKY, KAITLIN HAGAN, TINA LIU, KEVAL CHANDARANA, JASON L. GAGLIA, WENDY WOLF, JEOFFREY BISPHAM, KATHERINE S.M. CHAPMAN, DANIEL FINAN, JENNIFER SHERR

Diabetes 2022;71(Supplement_1):92-OR

DOI: https://doi.org/10.2337/db22-92-OR

Published: 01 June 2022

View article

Meeting Abstracts

759-P: Glycemic Outcomes over 15 Months with the Omnipod 5 Automated Insulin Delivery System

Diabetes 2022;71(Supplement_1):759-P

DOI: https://doi.org/10.2337/db22-759-P

Published: 01 June 2022

View article

Meeting Abstracts

100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results

Diabetes 2022;71(Supplement_1):100-LB

DOI: https://doi.org/10.2337/db22-100-LB

Published: 01 June 2022

View article

Meeting Abstracts

32-LB: Interstitial Glucose Levels during Exercise in Persons with and without Type 1 Diabetes

MICHAEL RIDDELL, ZHAOMIAN LI, NINOSCHKA DSOUZA, CHRISTOPHER YEUNG, DURMALOUK KESIBI, SUSANA R. PATTON, ROY BECK, PETER G. JACOBS, MARK A. CLEMENTS, ROBIN L. GAL, FRANCIS J. DOYLE, III, CORBY K. MARTIN, PETER CALHOUN, JENNIFER SHERR, JESSICA R. CASTLE, MICHAEL R. RICKELS

Diabetes 2021;70(Supplement_1):32-LB

DOI: https://doi.org/10.2337/db21-32-LB

Published: 01 June 2021

View article

Meeting Abstracts

717-P: Real-World, Patient-Reported Data on Training and Use of 670G Hybrid Closed-Loop (HCL) among Children and Adults with Type 1 Diabetes (T1D)

COLLEEN BAUZA, STEPHANIE DUBOSE, ALANDRA VERDEJO, ROY BECK, RICHARD M. BERGENSTAL, JENNIFER SHERR

Diabetes 2021;70(Supplement_1):717-P

DOI: https://doi.org/10.2337/db21-717-P

Published: 01 June 2021

View article

Meeting Abstracts

908-P: A Self-Assessment: Understanding Perceptions of New-Onset Type 1 Diabetes (T1D) Education in a Pediatric Tertiary Care Center

GABRIEL BETANCUR, MICHELLE N. BREI, KATE WEYMAN, LORI R. CARRIA, KERRY R. STEPHENSON, MICHELLE A. VAN NAME, JENNIFER SHERR

Diabetes 2021;70(Supplement_1):908-P

DOI: https://doi.org/10.2337/db21-908-P

Published: 01 June 2021

View article

Meeting Abstracts

917-P: Supervised Basal Insulin Injections Prevent Ketosis in Youth with Type 1 Diabetes (T1D)

LAURA M. NALLY, OLIVIA K. SOSNOSKI, JENNIFER SHERR, EILEEN M. TICHY, KATE WEYMAN, AMY STEFFEN, SARAH MCCOLLUM, VERONIKA SHABANOVA, WILLIAM V. TAMBORLANE, MICHELLE A. VAN NAME

Diabetes 2021;70(Supplement_1):917-P

DOI: https://doi.org/10.2337/db21-917-P

Published: 01 June 2021

View article

Meeting Abstracts

96-LB: Glycemic Management over 6 Months with the Omnipod 5 Automated Insulin Delivery System

Diabetes 2021;70(Supplement_1):96-LB

DOI: https://doi.org/10.2337/db21-96-LB

Published: 01 June 2021

View article

Meeting Abstracts

70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D)

JENNIFER SHERR, BRUCE W. BODE, GREGORY P. FORLENZA, LORI M. LAFFEL, SUE A. BROWN, BRUCE A. BUCKINGHAM, AMY B. CRIEGO, DANIEL DESALVO, SARAH A. MACLEISH, DAVID W. HANSEN, TRANG T. LY, OMNIPOD 5 IN PRESCHOOLERS STUDY GROUP

Diabetes 2021;70(Supplement_1):70-OR

DOI: https://doi.org/10.2337/db21-70-OR

Published: 01 June 2021

View article

Meeting Abstracts

145-OR: GLP-1 Analogue Effects on Neural Responses to High-Fructose Corn Syrup and Eating Behavior in Obesity

KELLY JOSEPH, JESSICA LEVENTHAL, SEUNGJU HWANG, MARI-LYNET KNIGHT, DONGJU SEO, CHERYL LACADIE, MICHELLE A. VAN NAME, SONIA CAPRIO, JENNIFER SHERR, WILLIAM V. TAMBORLANE, RAJITA SINHA, ANIA M. JASTREBOFF

Diabetes 2020;69(Supplement_1):145-OR

DOI: https://doi.org/10.2337/db20-145-OR

Published: 01 June 2020

View article

Meeting Abstracts

97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D

Diabetes 2020;69(Supplement_1):97-LB

DOI: https://doi.org/10.2337/db20-97-LB

Published: 01 June 2020

View article

Meeting Abstracts

978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia

GREGORY P. FORLENZA, BRUCE A. BUCKINGHAM, JENNIFER SHERR, R. PAUL WADWA, ALFONSO GALDERISI, LAYA EKHLASPOUR, CARI BERGET, LIANA HSU, MELINDA ZGORSKI, JOON BOK LEE, JASON B. OCONNOR, BONNIE DUMAIS, TODD VIENNEAU, LAUREN M. HUYETT, TRANG T. LY

Diabetes 2020;69(Supplement_1):978-P

DOI: https://doi.org/10.2337/db20-978-P

Published: 01 June 2020

View article

Meeting Abstracts

1580-P: Hemoglobin A1c (HbA1c) Trajectories of Youth with Type 1 Diabetes (T1D) over 10 Years Postdiagnosis from Three Continents

JENNIFER SHERR, ANKE SCHWANDT, HELEN PHELAN, MARK A. CLEMENTS, REINHARD W. HOLL, PAUL Z. BENITEZ-AGUIRRE, KELLEE MILLER, JOACHIM WOELFLE, THOMAS DOVER, DAVID M. MAAHS, ELKE FRÖHLICH-REITERER, MARIA E. CRAIG

Diabetes 2020;69(Supplement_1):1580-P

DOI: https://doi.org/10.2337/db20-1580-P

Published: 01 June 2020

View article

Meeting Abstracts

1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia

JENNIFER SHERR, BRUCE A. BUCKINGHAM, GREGORY P. FORLENZA, ALFONSO GALDERISI, LAYA EKHLASPOUR, R. PAUL WADWA, MELINDA ZGORSKI, RYAN S. KINGMAN, CARI BERGET, JOON BOK LEE, JASON B. OCONNOR, BONNIE DUMAIS, TODD VIENNEAU, LAUREN M. HUYETT, TRANG T. LY

Diabetes 2020;69(Supplement_1):1296-P

DOI: https://doi.org/10.2337/db20-1296-P

Published: 01 June 2020

View article

Meeting Abstracts

1304-P: Glycemic Trends in a Hockey Camp for Youth with Type 1 Diabetes (T1D)

MICHAEL RIDDELL, ZHAOMIAN LI, ROBIN L. GAL, ANNA MAZZUOCCOLO, ELLIS GREENE, II, PETER CALHOUN, LINDSEY C. BEAULIEU, MARK A. CLEMENTS, JENNIFER SHERR, SUSANA R. PATTON, ROY BECK

Diabetes 2020;69(Supplement_1):1304-P

DOI: https://doi.org/10.2337/db20-1304-P

Published: 01 June 2020

View article

Meeting Abstracts

2418-PUB: Incident Diabetes Complications among Women with T1D Based on Parity

SARIT POLSKY, NICOLE C. FOSTER, STEPHANIE DUBOSE, SHIVANI AGARWAL, SARAH LYONS, ANNE L. PETERS, GABRIEL I. UWAIFO, LINDA DIMEGLIO, JENNIFER SHERR, CAROL J. LEVY

Diabetes 2019;68(Supplement_1):2418-PUB

DOI: https://doi.org/10.2337/db19-2418-PUB

Published: 01 June 2019

View article

Meeting Abstracts

215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes

BRUCE A. BUCKINGHAM, GREGORY P. FORLENZA, JENNIFER SHERR, ALFONSO GALDERISI, LAYA EKHLASPOUR, JOON BOK LEE, JASON B. OCONNOR, BONNIE DUMAIS, LAUREN M. HUYETT, JENNIFER E. LAYNE, TRANG T. LY

Diabetes 2019;68(Supplement_1):215-OR

DOI: https://doi.org/10.2337/db19-215-OR

Published: 01 June 2019

View article

NARROW

33-OR: ADA Presidents' Select Abstract: Glycemic Outcomes over 12 Months in Very Young Children with the Omnipod 5 Automated Insulin Delivery (AID) System

766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years

765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years

92-OR: Persistence of Impaired Awareness of Hypoglycemia, Severe Hypoglycemic Events, and Suboptimal Glycemic Control Despite Advanced Diabetes Technologies

759-P: Glycemic Outcomes over 15 Months with the Omnipod 5 Automated Insulin Delivery System

100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results

32-LB: Interstitial Glucose Levels during Exercise in Persons with and without Type 1 Diabetes

717-P: Real-World, Patient-Reported Data on Training and Use of 670G Hybrid Closed-Loop (HCL) among Children and Adults with Type 1 Diabetes (T1D)

908-P: A Self-Assessment: Understanding Perceptions of New-Onset Type 1 Diabetes (T1D) Education in a Pediatric Tertiary Care Center

917-P: Supervised Basal Insulin Injections Prevent Ketosis in Youth with Type 1 Diabetes (T1D)

96-LB: Glycemic Management over 6 Months with the Omnipod 5 Automated Insulin Delivery System

70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D)

145-OR: GLP-1 Analogue Effects on Neural Responses to High-Fructose Corn Syrup and Eating Behavior in Obesity

97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D

978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia

1580-P: Hemoglobin A1c (HbA1c) Trajectories of Youth with Type 1 Diabetes (T1D) over 10 Years Postdiagnosis from Three Continents

1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia

1304-P: Glycemic Trends in a Hockey Camp for Youth with Type 1 Diabetes (T1D)

2418-PUB: Incident Diabetes Complications among Women with T1D Based on Parity

215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only